Register for email alerts and news feeds:
This journal | BMJ Group
rss
Heart 1999;82:319-324; doi:10.1136/hrt.82.3.319
Copyright © 1999 BMJ Publishing Group Ltd & British Cardiovascular Society
Heart 1999;82:319-324 ( September )

Incidence and modes of onset of early reinitiation of atrial fibrillation after successful internal cardioversion, and its prevention by intravenous sotalol

H-F Tsea, C-P Laua, G M Ayersb

a Department of Medicine, Division of Cardiology, University of Hong Kong, Queen Mary Hospital, Hong Kong, China, b InControl Inc, Redmond, Washington, USA

Correspondence to: Professor Lau. email: cplau{at}hkucc.hku.hk

Accepted for publication 8 April 1999

OBJECTIVES---To study the incidence and mode of onset of early reinitiation of atrial fibrillation (ERAF) following successful internal cardioversion of chronic atrial fibrillation, and to determine the effects of sotalol in the prevention of ERAF.
DESIGN---The incidence and modes of onset of ERAF and the acute effects of intravenous sotalol in the prevention of ERAF were studied retrospectively.
SETTING---Electrophysiology laboratory at a university teaching hospital.
PATIENTS---64 patients, mean (SD) age 62 (10) years, who underwent internal cardioversion of chronic atrial fibrillation (mean duration of atrial fibrillation 31 (39) months).
MAIN OUTCOME MEASURES---ECGs and intracardiac electrograms recorded during the internal cardioversion of atrial fibrillation using 3/3 ms biphasic, R wave synchronised shocks.
RESULTS---52 patients (81%) had successful electrical cardioversion, and 20 (31%) of these had ERAF during the procedure. There was no clinical predictor for the occurrence of ERAF. Fifty eight episodes of ERAF were observed. Five ERAF episodes (9%) had preceding bradycardia and 53 (91%) of these were triggered by atrial premature beats with normal preceding heart rate. Atrial premature beats that reinitiated atrial fibrillation had a shorter coupling interval (333 (43) ms v 396 (100), p < 0.001) and a lower prematurity index (0.44 (0.11) v 0.55 (0.14), p < 0.001) than those that did not reinitiate atrial fibrillation. Repeated shock delivery and increasing the defibrillation energy did not prevent ERAF. Intravenous sotalol infusion decreased the numbers of atrial premature beats and prolonged their coupling interval, and prevented ERAF after repeated defibrillation in 83% of patients with ERAF.
CONCLUSIONS---ERAF is a significant clinical problem after successful internal cardioversion of chronic atrial fibrillation, and was observed in up to 31% of patients. In most episodes, ERAF was triggered by short coupling atrial premature beats with preceding normal heart rate. Intravenous sotalol was effective in preventing ERAF in most cases.


Keywords: atrial fibrillation; low energy cardioversion; sotalol


© 1999 by Heart

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Purerfellner, H., Urban, L., de Weerd, G., Ruiter, J., Brandt, J., Havlicek, A., Hugl, B., Widdershoven, J., Kornet, L., Kessels, R. (2009). Reduction of atrial fibrillation burden by atrial overdrive pacing: experience with an improved algorithm to reduce early recurrences of atrial fibrillation. Europace 11: 62-69 [Abstract] [Full Text]  
  • Camm, A. J., Kirchhof, P., Lip, G. Y.H., Savelieva, I., Ernst, S. (2009). CHAPTER 29 Atrial Fibrillation. ESC Textbook of Cardiovascular Medicine 2: med-9780199566990-chapter-med-9780199566990-chapter [Abstract] [Full Text]  
  • Hoffmann, E., Sulke, N., Edvardsson, N., Ruiter, J., Lewalter, T., Capucci, A., Schuchert, A., Janko, S., Camm, J., on behalf of the Atrial Fibrillation Therapy (AFT), (2006). New Insights Into the Initiation of Atrial Fibrillation: A Detailed Intraindividual and Interindividual Analysis of the Spontaneous Onset of Atrial Fibrillation Using New Diagnostic Pacemaker Features. Circulation 113: 1933-1941 [Abstract] [Full Text]  
  • Siaplaouras, S., Jung, J., Buob, A., Heisel, A. (2004). Incidence and management of early recurrent atrial fibrillation (ERAF) after transthoracic electrical cardioversion. Europace 6: 15-20 [Abstract] [Full Text]  
  • Geller, J.C., Reek, S., Timmermans, C., Kayser, T., Tse, H.-F., Wolpert, C., Jung, W., Camm, A.J., Lau, C.-P., Wellens, H. J.J., Klein, H. U. (2003). Treatment of atrial fibrillation with an implantable atrial defibrillator -- long term results. Eur Heart J 24: 2083-2089 [Abstract] [Full Text]  
  • Ueng, K.-C., Tsai, T.-P., Yu, W.-C., Tsai, C.-F., Lin, M.-C., Chan, K.-C., Chen, C.-Y., Wu, D.-J., Lin, C.-S., Chen, S.-A. (2003). Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation: Results of a prospective and controlled study. Eur Heart J 24: 2090-2098 [Abstract] [Full Text]  
  • Gorenek, B., Kudaiberdieva, G., Goktekin, O., Cavusoglu, Y., Birdane, A., Unalir, A., Ata, N., Timuralp, B. (2003). Long-short sequence may predict immediate recurrence of atrial fibrillation after external cardioversion. Europace 5: 11-16 [Abstract]  
  • Lau, C.-P. (2003). Pacing for atrial fibrillation. Heart 89: 106-112 [Full Text]  
  • Tse, H.-F., Lau, C.-P. (2002). Electrophysiologic actions of dl-sotalolin patients with persistent atrial fibrillation. J Am Coll Cardiol 40: 2150-2155 [Abstract] [Full Text]  
  • Schwartzman, D., Musley, S. K., Swerdlow, C., Hoyt, R. H., Warman, E. N. (2002). early recurrence of atrial fibrillation after ambulatory shock conversion. J Am Coll Cardiol 40: 93-99 [Abstract] [Full Text]  
  • Qin, H., Walcott, G. P., Killingsworth, C. R., Rollins, D. L., Smith, W. M., Ideker, R. E. (2002). Impact of Myocardial Ischemia and Reperfusion on Ventricular Defibrillation Patterns, Energy Requirements, and Detection of Recovery. Circulation 105: 2537-2542 [Abstract] [Full Text]  
  • Veloso, H.H. (2001). Effects of oral sotalol administration before electrical cardioversion of persistent atrial fibrillation. Eur Heart J 22: 1512-1514  
  • Lu, T.-M., Tai, C.-T., Hsieh, M.-H., Tsai, C.-F., Lin, Y.-K., Yu, W.-C., Tsao, H.-M., Lee, S.-H., Ding, Y.-A., Chang, M.-S., Chen, S.-A. (2001). Electrophysiologic characteristics in initiation of paroxysmal atrial fibrillation from a focal area. J Am Coll Cardiol 37: 1658-1664 [Abstract] [Full Text]  
  • Derakhchan, K., Villemaire, C., Talajic, M., Nattel, S. (2001). The class III antiarrhythmic drugs dofetilide and sotalol prevent AF induction by atrial premature complexes at doses that fail to terminate AF. Cardiovasc Res 50: 75-84 [Abstract] [Full Text]  
  • Peters, N.S. (2000). Post-cardioversion atrial fibrillation: the synthesis of modern concepts?. Eur Heart J 21: 1119-1121  
  • Tse, H.-F., Lau, C.-P., Ayers, G.M. (2000). Atrial pacing for suppression of early reinitiation of atrial fibrillation after successful internal cardioversion. Eur Heart J 21: 1167-1176 [Abstract]  
  • Lam, C. T. F., Lau, C.-P., Leung, S.-K., Tse, H.-F., Lee, K. L. F., Tang, M.-O., Tsang, V. (2000). Efficacy and tolerability of continuous overdrive atrial pacing in atrial fibrillation. Europace 2: 286-291 [Abstract]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.